The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Analysis of interventional therapy for primary liver cancer in 67 cases
Author(s): 
Pages: 657-659
Year: Issue:  8
Journal: CHINA MEDICAL ENGINEERING

Keyword:  原发性肝癌介入治疗临床疗效;
Abstract: 目的 探讨原发性肝癌的灌注化疗加栓塞治疗的临床疗效.方法 收集该院67例原发性肝癌患者,采用灌注化疗加栓塞治疗进行治疗,均采用Seldinger技术,经皮股动脉穿刺插管.结果 全组2、4、6、8、12和24个月生存率分别为95.52%、92.53%、77.61%、65.67%、50.75%和16.41%.结论 采用灌注化疗加栓塞治疗进行治疗,对提高肝癌患者近期治疗效果及延长生存期具有重要作用.
Related Articles
loading...